Antitumor Activity of Gold, Silver, and Copper Complexes with Chiral Phosphines
Author Information
Author(s): Mark J. McKeage, Peter Papathanasiou, Geoffrey Salem, Allan Sjaarda, Gerhard F. Swiegers, Paul Waring, S. Bruce Wild
Primary Institution: The University of Auckland
Hypothesis
The study investigates the cytotoxic effects of gold(I), silver(I), and copper(I) complexes containing chiral tertiary phosphine ligands against various tumor cell lines.
Conclusion
Certain gold(I), silver(I), and copper(I) complexes exhibit significant cytotoxicity comparable to cisplatin, particularly in the presence of chiral ligands.
Supporting Evidence
- IC50 values for the most active compounds were in the range of 0.01 to 0.04 µM.
- Silver(I) complexes showed significantly higher activities towards the P815 melanoma cell line than gold(I) and copper(I) counterparts.
- The cytotoxicities of many complexes were comparable to that of cisplatin.
- The chirality of the ligand had little effect on the overall activity of the complexes.
- Gold(I) complexes were shown to inhibit ATP synthase, leading to rapid cell death.
Takeaway
Some metal compounds can help fight cancer by stopping cancer cells from growing, and the shape of the molecules matters less than we thought.
Methodology
The study involved synthesizing various metal complexes and testing their cytotoxic effects on mouse and human tumor cell lines using IC50 values.
Limitations
The complexes were found to be too toxic for clinical use due to side effects related to mitochondrial function disruption.
Want to read the original?
Access the complete publication on the publisher's website